| Molecular MRD status and outcome after transplantation in NPM1-mutated AML R Dillon, R Hills, S Freeman, N Potter, J Jovanovic, A Ivey, AS Kanda, ... Blood, The Journal of the American Society of Hematology 135 (9), 680-688, 2020 | 136 | 2020 |
| Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia C Craddock, S Nagra, A Peniket, C Brookes, L Buckley, E Nikolousis, ... Haematologica 95 (6), 989, 2010 | 85 | 2010 |
| Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study EW Petersdorf, M Carrington, C O'hUigin, M Bengtsson, D De Santis, ... The Lancet Haematology 7 (1), e50-e60, 2020 | 73 | 2020 |
| Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial SJ Stanworth, S Killick, ZK McQuilten, M Karakantza, R Weinkove, ... British journal of haematology 189 (2), 279-290, 2020 | 67 | 2020 |
| COVID‐19 in bone marrow transplant recipients: reflecting on a single centre experience A Kanellopoulos, MZ Ahmed, B Kishore, R Lovell, C Horgan, S Paneesha, ... British journal of haematology 190 (2), e67, 2020 | 60 | 2020 |
| Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies E Nikolousis, S Nagra, S Paneesha, J Delgado, K Holder, L Bratby, ... Annals of hematology 89 (11), 1141-1145, 2010 | 55 | 2010 |
| Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes N Goardon, E Nikolousis, A Sternberg, WK Chu, C Craddock, ... haematologica 94 (8), 1160, 2009 | 40 | 2009 |
| Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study J Styczyński, G Tridello, A Xhaard, M Medinger, S Mielke, M Taskinen, ... Bone marrow transplantation 56 (5), 1171-1179, 2021 | 37 | 2021 |
| Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic … E Nikolousis, S Robinson, S Nagra, C Brookes, F Kinsella, S Tauro, ... Leukemia research 37 (5), 561-565, 2013 | 36 | 2013 |
| Midazolam in conjunction with local anaesthesia is superior to Entonox in providing pain relief during bone marrow aspirate and trephine biopsy G Chakupurakal, J Delgado, E Nikolousis, S Pitchapillai, D Allotey, ... Journal of clinical pathology 61 (9), 1051-1054, 2008 | 28 | 2008 |
| Two cases of aspergillus endocarditis in non neutropenic children on chemotherapy for acute lymphoblastic leukaemia E Nikolousis, M Velangi Hematology Reports 3 (1), e7, 2011 | 15 | 2011 |
| Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease FAM Kinsella, CF Inman, A Gudger, YT Chan, DJ Murray, J Zuo, G McIlroy, ... Leukemia research 83, 106173, 2019 | 13 | 2019 |
| Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow … E Nikolousis, S Nagra, R Pearce, J Perry, K Kirkland, J Byrne, F Dignan, ... Bone Marrow Transplantation 50 (1), 82-86, 2015 | 13 | 2015 |
| Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from … AH Bazarbachi, R Al Hamed, M Labopin, K Halaburda, H Labussiere, ... Bone marrow transplantation 56 (4), 917-927, 2021 | 12 | 2021 |
| Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working … JC Hernández-Boluda, A Pereira, N Zinger, L Gras, R Martino, ... Bone marrow transplantation 57 (3), 416-422, 2022 | 11 | 2022 |
| CMV~ IMPACT: results of a randomized controlled trial of immuno-prophylactic adoptive cellular therapy following sibling donor allogeneic HSCT KS Peggs, E Tholouli, R Chakraverty, E Nikolousis, A Bloor, S Devereux, ... Blood 124 (21), 1109, 2014 | 9 | 2014 |
| Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm A Lokare, E Nikolousis, N Phillips, Z Rudzki, R Lovell, B Kishore, ... Hematology reports 6 (1), 5119, 2014 | 9 | 2014 |
| Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT R Machowicz, F Suarez, W Wiktor-Jedrzejczak, DJ Eikema, ... Bone marrow transplantation 57 (5), 817-823, 2022 | 7 | 2022 |
| Molecular advances in sinusoidal obstruction syndrome/Veno-occlusive disease I Mavrikou, D Chatzidimitriou, L Skoura, E Nikolousis, I Sakellari, ... International Journal of Molecular Sciences 24 (6), 5620, 2023 | 6 | 2023 |
| Remission status at transplantation and treatment history determine the survival chances of patients after allogeneic hematopoietic stem cell transplantation for chronic … J Schetelig, P Chevallier, M Van Gelder, J Hoek, O Hermine, ... Blood 130, 4576, 2017 | 6 | 2017 |
